v3.26.1
Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 8,425 $ 19,903,796 $ (8,581) $ (17,562,057) $ 2,341,583
Balance, shares at Dec. 31, 2024 8,424,600        
Issuance of common stock upon exercise of warrant related to convertible debt $ 1,000 999,000 1,000,000
Issuance of common stock upon exercise of warrant related to convertible debt, shares   1,000,000        
Issuance of common stock upon exercise of warrants $ 175 172,983 173,158
Issuance of common stock upon exercise of warrants, shares   174,747        
Stock-based compensation expense 81,097 81,097
Foreign currency translation adjustment 28,763 28,763
Net loss (2,521,538) (2,521,538)
Fair value adjustment related to warrant modification 32,099 32,099
Issuance of common stock under ATM program, net of issuance costs $ 1,120 2,406,328 2,407,448
Issuance of common stock under ATM program, net of issuance costs, shares   1,120,422        
Ending balance, value at Jun. 30, 2025 $ 10,720 23,595,303 20,182 (20,083,595) 3,542,610
Balance, shares at Jun. 30, 2025 10,719,769        
Beginning balance, value at Mar. 31, 2025 $ 9,585 22,352,265 (372) (18,480,439) 3,881,039
Balance, shares at Mar. 31, 2025 9,584,769        
Issuance of common stock upon exercise of warrant related to convertible debt $ 1,000 999,000 1,000,000
Issuance of common stock upon exercise of warrant related to convertible debt, shares   1,000,000        
Issuance of common stock upon exercise of warrants $ 135 134,865 135,000
Issuance of common stock upon exercise of warrants, shares   135,000        
Stock-based compensation expense 77,074 77,074
Foreign currency translation adjustment 20,554 20,554
Net loss (1,603,156) (1,603,156)
Fair value adjustment related to warrant modification 32,099 32,099
Ending balance, value at Jun. 30, 2025 $ 10,720 23,595,303 20,182 (20,083,595) 3,542,610
Balance, shares at Jun. 30, 2025 10,719,769        
Beginning balance, value at Dec. 31, 2025 $ 13,385 29,218,186 26,865 (23,686,729) 5,571,707
Balance, shares at Dec. 31, 2025 13,385,459        
Issuance of common stock upon exercise of warrant related to convertible debt $ 500 749,500 750,000
Issuance of common stock upon exercise of warrant related to convertible debt, shares   500,000        
Issuance of common stock upon exercise of warrants $ 272 270,842 $ 271,114
Issuance of common stock upon exercise of warrants, shares   271,115      
Stock-based compensation expense 515,744 $ 515,744
Foreign currency translation adjustment (56,414) (56,414)
Net loss (4,512,320) (4,512,320)
Issuance of common stock under ATM program, net of issuance costs $ 500 1,428,544 1,429,044
Issuance of common stock under ATM program, net of issuance costs, shares   500,000        
Issuance of common stock in connection with debt conversion $ 659 499,341 500,000
Issuance of common stock in connection with debt conversion, shares   659,457        
Ending balance, value at Jun. 30, 2026 $ 15,316 32,682,157 (29,549) (28,199,049) 4,468,875
Balance, shares at Jun. 30, 2026 15,316,031        
Beginning balance, value at Mar. 31, 2026 $ 14,582 31,426,345 (29,380) (25,479,013) 5,932,534
Balance, shares at Mar. 31, 2026 14,582,416        
Issuance of common stock upon exercise of warrant related to convertible debt $ 500 749,500 750,000
Issuance of common stock upon exercise of warrant related to convertible debt, shares   500,000        
Issuance of common stock upon exercise of warrants $ 234 233,380 233,614
Issuance of common stock upon exercise of warrants, shares   233,615        
Stock-based compensation expense 272,932 272,932
Foreign currency translation adjustment (169) (169)
Net loss (2,720,036) (2,720,036)
Ending balance, value at Jun. 30, 2026 $ 15,316 $ 32,682,157 $ (29,549) $ (28,199,049) $ 4,468,875
Balance, shares at Jun. 30, 2026 15,316,031